Trial Profile
An observational, multicentre study of telaprevir-based-therapy in patients with moderate fibrosis and advanced liver fibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Fibrosis; Hepatic fibrosis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record